Gilead Sciences Inc. News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.
Cramer's Mad Money Recap 3/18: Nike, Nvidia, Adobe
Game plan for the week ahead with earnings from Nike, Adobe, KB Home and a keynote from Nvidia's CEO.
Cramer's Mad Money Recap 2/4: Take-Two Interactive, Disney, Twitter
Earnings from Take-Two Interactive, Disney and Twitter highlight Jim Cramer's game plan for next week.
Gilead Sciences Sues to Block Sellers of Counterfeit HIV Meds
Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.
Stock Market Today-6/24: Dow Surges 800 Points As 'Relief Rally' Defies Global Growth Concerns
Stocks finished sharply higher Friday as investors rode a so-called 'relief rally' while re-setting other market prices for a near-term recession.
These Five Things Could Help (or Hurt) Internet Stocks
Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.